Chalkias, Spyros http://orcid.org/0000-0002-6254-1158
Whatley, Jordan L.
Eder, Frank
Essink, Brandon
Khetan, Shishir
Bradley, Paul
Brosz, Adam
McGhee, Nichole
Tomassini, Joanne E. http://orcid.org/0000-0002-9399-2867
Chen, Xing http://orcid.org/0000-0002-6740-9535
Zhao, Xiaoping
Sutherland, Andrea
Shen, Xiaoying http://orcid.org/0000-0002-8387-3952
Girard, Bethany
Edwards, Darin K. http://orcid.org/0000-0002-2065-2941
Feng, Jing
Zhou, Honghong
Walsh, Stephen http://orcid.org/0000-0002-0817-9370
Montefiori, David C.
Baden, Lindsey R.
Miller, Jacqueline M.
Das, Rituparna
Article History
Received: 13 March 2023
Accepted: 27 July 2023
First Online: 31 August 2023
Competing interests
: J.W., F.E., B.E., S.K., P.B. and A.B. report fees received for trial activities from Meridian Clinical Research that were funded by Moderna. X.S. and D.C.M. report funding from Moderna, Inc. for pseudovirus neutralization assays performed in the study. S.R.W. has conducted clinical trials funded by NIAID/NIH Moderna, Inc., Janssen Vaccines and Sanofi Pasteur. L.R.B. is a co-primary principal investigator of the COVE trial funded by NIAID and conducted in conjunction with Moderna, Inc. S.C., N.M., X.C., X.Z., A.S., B.G., D.K.E., J.F., H.Z., J.M.M. and R.D. are employees of Moderna, Inc. and may hold stock/stock options in the company. J.E.T. is a Moderna consultant.